Literature DB >> 15542932

Radiosurgical planning of meningiomas: compromises with conformity.

Jeremy G Rowe1, Lee Walton, Paul Vaughan, Irfan Malik, Matthias Radatz, Andras Kemeny.   

Abstract

The radiosurgical planning of meningiomas frequently necessitates compromises between irradiating tumour and risking damage to adjacent structures. In selected cases, we resolved this by excluding part of the tumour from the prescription isodose volume. Most of these compromises or 'suboptimal' plans achieved growth control. Growth control could not be related to conformity indices or to various measures of the radiation dose received by the meningioma. Examining recurrences, 75% arose from dura outside the original treatment field. These findings are discussed in terms of dose prescription protocols and the use of conformity indices in planning. The importance of the dural origin of meningiomas is well established in surgical practice, as reflected by Simpson's grades, but may be equally significant in radiosurgical practice. 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2004        PMID: 15542932     DOI: 10.1159/000082041

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  3 in total

1.  Characterisation of dose distribution in linear accelerator-based intracranial stereotactic radiosurgery with the dynamic conformal arc technique: consideration of the optimal method for dose prescription and evaluation.

Authors:  K Ohtakara; S Hayashi; H Hoshi
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

2.  The relation between various conformity indices and the influence of the target coverage difference in prescription isodose surface on these values in intracranial stereotactic radiosurgery.

Authors:  K Ohtakara; S Hayashi; H Hoshi
Journal:  Br J Radiol       Date:  2011-09-21       Impact factor: 3.039

Review 3.  The cavernous sinus meningiomas' dilemma: Surgery or stereotactic radiosurgery?

Authors:  Laura Fariselli; Antonio Biroli; Antonio Signorelli; Morgan Broggi; Marcello Marchetti; Francesco Biroli
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.